Dr. Patt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2410 Round Rock Ave
Ste 150
Round Rock, TX 78681Phone+1 512-427-9400Fax+1 512-687-0295- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2003 - 2006
Baylor College of MedicineResidency, Internal Medicine/Pediatrics, 1999 - 2003- Baylor College of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2003 - 2025
MT State Medical License 2022 - 2024
NE State Medical License 2022 - 2024
ME State Medical License 2022 - 2024
IA State Medical License 2022 - 2024
NH State Medical License 2022 - 2024
ND State Medical License 2022 - 2024- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
- Join now to see all
Clinical Trials
- A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread Start of enrollment: 2014 Jun 10
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Start of enrollment: 2017 Feb 02
Publications & Presentations
PubMed
- Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity.Joshua C Pritchett, Debra Patt, Gita Thanarajasingam, Anne Schuster, Claire Snyder> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
- 3 citationsOverall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phas...Frankie A Holmes, Beverly Moy, Suzette Delaloge, Stephen K L Chia, Bent Ejlertsen, Janine Mansi, Hiroji Iwata, Michael Gnant, Marc Buyse, Carlos H Barrios, Tajana Silo...> ;European Journal of Cancer. 2023 May 1
- Tenets for Implementing Electronic Patient-Reported Outcomes for Remote Symptom Monitoring During Cancer Treatment.Ethan Basch, Gabrielle Rocque, Gita Mody, Samyukta Mullangi, Debra Patt> ;JCO Clinical Cancer Informatics. 2023 Feb 1
- Join now to see all
Lectures
- Operationalizing a Risk Model in Clinical Practice: A Community Oncology PerspectiveASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Understanding Utilization Management-Policy Background: Forms of Utilization Management From a Clinician Perspective.2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Authored Content
- Using ePROs to Improve Symptom Management and Provide Value-Based CareMarch 2021
Press Mentions
Viewpoint: Protect Cancer Patients by Eliminating PBM Mail-Order Pharmacy RequirementsMay 15th, 2023- Community Oncology: The Next 20 YearsMarch 25th, 2023
- Texas Lawmakers Push for Insurers to Cover Biomarker Testing for CancerMarch 21st, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Ascension Seton Medical Center AustinAustin, Texas- Cornerstone Hospital of CentralTXAustin, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
